Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis
This analysis compared adverse event rates in patients with significant blood loss versus those without this complication in trials evaluating the nonsteroidal anti-inflammatory drugs celecoxib. An association was found between significant blood loss and serious cardiac complications. This study suggests that patients who bleed more frequently have underlying cardiac disease, rather that anemia leads to myocardial infarction.
Jeffrey L. Carson
NATA: Network for the advancement of Patient Blood Management, Haemostasis and Thrombosis
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and ther heathcare professionals.
I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.